Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mignot

Showing results (81-90 of 165) with videos related to

Pageof 17
Sort By:
European Journal of Neurology|December 23, 2004
Hypocretin deficiency in Prader-Willi syndromeS Nevsimalova, J Vankova, I Stepanova, et al.
Neuroreport|April 17, 2001
Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivationN Fujiki, Y Yoshida, B Ripley, et al.
Neurology|August 28, 2002
Increased CSF hypocretin-1 (orexin-A) in restless legs syndromeR P Allen, E Mignot, B Ripley, et al.
Neuroscience Research|February 13, 2001
Is narcolepsy a REM sleep disorder? Analysis of sleep abnormalities in narcoleptic DobermansS Nishino, J Riehl, J Hong, et al.
The Journal of Heredity|February 13, 1999
Genetic studies in narcolepsy, a disorder affecting REM sleepJ Faraco, X Lin, R Li, et al.
Sleep Medicine|November 29, 2024
Characteristics of the differential response to exercise in adults with restless legs syndromeK L J Cederberg, G C Ricciardiello Mejia, E M Sikes, et al.
Genome Research|April 3, 2001
Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic caninesM Hungs, J Fan, L Lin, et al.
Brain Research|October 23, 1989
Canine narcolepsy is associated with an elevated number of alpha 2-receptors in the locus coeruleusB Fruhstorfer, E Mignot, S Bowersox, et al.
Neuroreport|August 12, 1996
Thalidomide, a hypnotic with immune modulating properties, increases cataplexy in canine narcolepsyT Kanbayashi, S Nishino, M Tafti, et al.
Psychopharmacology|January 1, 1993
Canine cataplexy is preferentially controlled by adrenergic mechanisms: evidence using monoamine selective uptake inhibitors and release enhancersE Mignot, A Renaud, S Nishino, et al.
Pageof 17

Showing results (81-90 of 165) with videos related to

Sort By:
Pageof 17
European Journal of Neurology|December 23, 2004
Hypocretin deficiency in Prader-Willi syndromeS Nevsimalova, J Vankova, I Stepanova, et al.
Neuroreport|April 17, 2001
Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivationN Fujiki, Y Yoshida, B Ripley, et al.
Neurology|August 28, 2002
Increased CSF hypocretin-1 (orexin-A) in restless legs syndromeR P Allen, E Mignot, B Ripley, et al.
Neuroscience Research|February 13, 2001
Is narcolepsy a REM sleep disorder? Analysis of sleep abnormalities in narcoleptic DobermansS Nishino, J Riehl, J Hong, et al.
The Journal of Heredity|February 13, 1999
Genetic studies in narcolepsy, a disorder affecting REM sleepJ Faraco, X Lin, R Li, et al.
Sleep Medicine|November 29, 2024
Characteristics of the differential response to exercise in adults with restless legs syndromeK L J Cederberg, G C Ricciardiello Mejia, E M Sikes, et al.
Genome Research|April 3, 2001
Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic caninesM Hungs, J Fan, L Lin, et al.
Brain Research|October 23, 1989
Canine narcolepsy is associated with an elevated number of alpha 2-receptors in the locus coeruleusB Fruhstorfer, E Mignot, S Bowersox, et al.
Neuroreport|August 12, 1996
Thalidomide, a hypnotic with immune modulating properties, increases cataplexy in canine narcolepsyT Kanbayashi, S Nishino, M Tafti, et al.
Psychopharmacology|January 1, 1993
Canine cataplexy is preferentially controlled by adrenergic mechanisms: evidence using monoamine selective uptake inhibitors and release enhancersE Mignot, A Renaud, S Nishino, et al.
Pageof 17